PATENT CLAIM ANALYSIS

Application Number: 15923011
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "139100"]

Abstract:
Monoclonal anti-PHF-tau antibodies and antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies and using the antibodies for treating or preventing conditions such as tauopathies.

Claim (Index 16):
A pharmaceutical composition comprising the isolated monoclonal antibody or antigen-binding fragment of  claim 1  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13716526', '14309330', '15559791', '15818090', '14774512']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8029042528947332
- 35 USC 102 Novelty (BERT): 0.5829395194222985
- Combined Prediction Score: 0.7809077795474898
- Mean Citation Score: 493.22498800000005
- Max Citation Score: 508.12195
- Similarity Product: 434.3230403690428

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test